Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
23 participants
INTERVENTIONAL
2011-01-31
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hypnosis for Fear of Falling in Older Adults
NCT04726774
Developing a Low-Intensity Primary Care Intervention for Anxiety Disorders
NCT02266446
Improving Quality of Primary Care for Patients With Anxiety and/or Panic Disorders
NCT00102427
Developing a Novel Digital Therapeutic for the Treatment of Generalized Anxiety Disorder
NCT03683472
Testing Beliefs About Uncertainty in the Treatment of Generalized Anxiety Disorder
NCT01958788
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After an initial study assessment, participants will complete 8 home-based sessions of a Cognitive-Behavioral therapy (CBT). The sessions will be led by a study clinician who will cover the 5 intervention components:(a) education (learning about anxiety and the rationale for treatment); (b) relaxation training (learning skills to reduce tension); (c) cognitive restructuring (learning skills needed to cope better with distressing thoughts); (d) behavioral activation (learning to initiate healthy activity); and (e) exposure (coaching in how to confront avoided thoughts, situations, and people).
Participants will also complete assessments following completion of the intervention and 3 months after completion of the intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive Behavioral Exposure Therapy
Education
Learning about anxiety
Relaxation Training
Learning skills to reduce tension
Cognitive Restructuring
Learning skills needed to cope better with distressing thoughts
Behavioral Activation
Learning to initiate healthy activity
Exposure
Coaching in how to confront avoided thoughts, situations, and people)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education
Learning about anxiety
Relaxation Training
Learning skills to reduce tension
Cognitive Restructuring
Learning skills needed to cope better with distressing thoughts
Behavioral Activation
Learning to initiate healthy activity
Exposure
Coaching in how to confront avoided thoughts, situations, and people)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English-speaking
* injured due to fall
* hospitalized
* returned home \< or = 3 months
* ambulatory
* full or subsyndromal PTSD or Fear of Falling
* residing in one of the five boroughs of New York City
Exclusion Criteria
* Marked cognitive impairment
* Dementia
* Schizophrenia
* Bipolar Disorder
* Depression with psychotic features
* Delusional Disorder
* Substance Use Disorder or Dependence
* Active suicidal ideation, intent, or plan
* Active homicidal ideation, intent or plan
* Aphasia
* Acute or severe medical illness or life expectancy \< 6 months
* Initiated psychotropic medications \< 6 weeks prior
* Initiated mental health treatment \< 6 weeks prior
* Psychosocial factors that would compromise study participation (such as not having a telephone)
65 Years
105 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nimali Jayasinghe
Assistant Professor of Psychology in Clinical Psychiatry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nimali Jayasinghe, PhD
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Weill Cornell Medical College
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K23 MH 09244
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.